Variant report
Variant | esv3389740 |
---|---|
Chromosome Location | chr1:211283829-211286827 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs537130978 | chr1:211283844-211283845 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs536911778 | chr1:211283860-211283861 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs1538289 | chr1:211283875-211283876 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs569510608 | chr1:211283912-211283913 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs574693912 | chr1:211283933-211283934 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs35286074 | chr1:211283963-211283964 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs35091753 | chr1:211283985-211283986 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs560156812 | chr1:211283989-211283990 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs1538288 | chr1:211284011-211284012 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs142005630 | chr1:211284041-211284042 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs572273151 | chr1:211284048-211284049 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs199545153 | chr1:211284058-211284059 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs4951505 | chr1:211284060-211284061 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs552584075 | chr1:211284114-211284115 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs4951506 | chr1:211284128-211284129 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs550179809 | chr1:211284143-211284144 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs145755293 | chr1:211284322-211284323 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs77246981 | chr1:211284356-211284357 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs182167270 | chr1:211284362-211284363 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs565706173 | chr1:211284440-211284441 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs539523077 | chr1:211284441-211284442 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs551468433 | chr1:211284451-211284452 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs569721448 | chr1:211284581-211284582 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs529069207 | chr1:211284598-211284599 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs142503322 | chr1:211284624-211284625 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs148856976 | chr1:211284643-211284644 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs538037282 | chr1:211284653-211284654 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs368389070 | chr1:211284671-211284672 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs534649120 | chr1:211284693-211284694 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs563378369 | chr1:211284721-211284722 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs185429043 | chr1:211284726-211284727 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs572142825 | chr1:211284765-211284766 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs78357656 | chr1:211284815-211284816 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs558253802 | chr1:211284820-211284821 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs117503748 | chr1:211284842-211284843 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs191366735 | chr1:211284852-211284853 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs562191705 | chr1:211284876-211284877 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs148353889 | chr1:211284918-211284919 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs541778656 | chr1:211284967-211284968 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs61099314 | chr1:211284974-211284975 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs183199558 | chr1:211285010-211285011 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs142097300 | chr1:211285035-211285036 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs188658124 | chr1:211285089-211285090 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs28461790 | chr1:211285114-211285115 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs569738921 | chr1:211285150-211285151 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs372126375 | chr1:211285151-211285152 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs376748003 | chr1:211285172-211285173 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs56741924 | chr1:211285187-211285188 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs549160001 | chr1:211285202-211285203 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs374079471 | chr1:211285209-211285210 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Liposarcoma | 21253554 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Breast cancer | 21509527 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17393978 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chordoma | 18071362 | CNVD |
Macular degeneration | 22558131 | CNVD |
Alzheimer''s disease | 21403675 | CNVD |
Multiple myeloma | 16461302 | CNVD |
van der Woude syndrome | 22470819 | CNVD |
van der Woude syndrome | 20818247 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 17060936 | CNVD |
Atypical hemolytic uremic syndrome | 19861685 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Urothelial tumor | 18831757 | CNVD |
Lung cancer | 18438408 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:211256400-211285400 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr1:211271400-211286000 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr1:211280800-211290800 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
4 | chr1:211280800-211300200 | Weak transcription | HSMMtube | muscle |
5 | chr1:211282400-211286400 | Weak transcription | HSMM | muscle |
6 | chr1:211284600-211284800 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
7 | chr1:211285400-211285600 | Genic enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
8 | chr1:211285600-211299400 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
9 | chr1:211286000-211288000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
10 | chr1:211286400-211287000 | Strong transcription | HSMM | muscle |
11 | chr1:211286800-211287800 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |